CLINICAL SIGNIFICANCE OF COMBINING BCR-ABL1 TRANSCRIPT LEVELS AT 3 AND 6 MONTHS IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH FRONTLINE SECOND-GENERATION TYROSINE KINASE INHIBITORS

被引：0
|
作者：
Lee, S. E. [1 ,2 ]
Choi, S. Y. [2 ]
Kim, S. H. [2 ]
Oh, Y. J. [2 ]
Chae, M. J. [2 ]
Song, H. Y. [2 ]
Yoo, H. L. [2 ]
Lee, M. Y. [2 ]
Jang, E. J. [2 ]
Jeong, K. H. [2 ]
Lee, J. S. [2 ]
Kim, D. W. [1 ,2 ]
机构：
[1] Catholic Univ Korea, Seoul St Marys Hosp, Dept Hematol, Seoul, South Korea
[2] Catholic Univ Korea, Canc Res Inst, Seoul, South Korea
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1546
引用
收藏
页码：599 / 599
页数：1
相关论文
共 50 条
  • [31] CLINICAL SIGNIFICANCE OF EARLY MOLECULAR RESPONSES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH FIRST-LINE SECOND-GENERATION TYROSINE KINASE INHIBITORS
    Lee, S.
    Choi, S.
    Kim, S.
    Bang, J.
    Oh, Y.
    Park, J.
    Jeon, H.
    Jang, E.
    Kim, D.
    HAEMATOLOGICA, 2013, 98 : 51 - 52
  • [32] BCR-ABL1 transcript at 3months predicts long-term outcomes following second generation tyrosine kinase inhibitor therapy in the patients with chronic myeloid leukaemia in chronic phase who failed Imatinib
    Kim, Dennis D.
    Lee, Honggi
    Kamel-Reid, Suzanne
    Lipton, Jeffrey H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (05) : 630 - 639
  • [33] Oxidative Stress and BCR-ABL1 Transcript Levels in Chronic Myeloid Leukemia: an Intricate Relationship
    Pascu, Emilia Georgiana
    Gaman, Mihnea Alexandru
    Moisa, Cornel
    Gaman, Amelia Maria
    REVISTA DE CHIMIE, 2019, 70 (09): : 3193 - 3196
  • [34] Improved Drug Adherence in Patients with Chronic Myeloid Leukemia in the Chronic Phase by Switching to Second-Generation Tyrosine Kinase Inhibitors
    Maeda, Yasuhiro
    Okamoto, Atsushi
    Kawaguchi, Shin-ichiro
    Konishi, Akiko
    Yamamoto, Kenta
    Eguchi, Go
    Kanai, Yoshitaka
    Yamaguchi, Terufumi
    ACTA HAEMATOLOGICA, 2017, 138 (03) : 140 - 142
  • [35] Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line
    Stephanie Dulucq
    Gabriel Etienne
    Stephane Morisset
    Emilie Klein
    Claudine Chollet
    Fanny Robbesyn
    Beatrice Turcq
    Isabelle Tigaud
    Sandrine Hayette
    Franck E. Nicolini
    François-Xavier Mahon
    Annals of Hematology, 2019, 98 : 1159 - 1168
  • [36] Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia
    Z Gong
    L J Medeiros
    J E Cortes
    L Zheng
    J D Khoury
    W Wang
    G Tang
    S Loghavi
    R Luthra
    W Yang
    H M Kantarjian
    S Hu
    Blood Cancer Journal, 2017, 7 : e583 - e583
  • [37] Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia
    Gong, Z.
    Medeiros, L. J.
    Cortes, J. E.
    Zheng, L.
    Khoury, J. D.
    Wang, W.
    Tang, G.
    Loghavi, S.
    Luthra, R.
    Yang, W.
    Kantarjian, H. M.
    Hu, S.
    BLOOD CANCER JOURNAL, 2017, 7 : e583 - e583
  • [38] Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line
    Dulucq, Stephanie
    Etienne, Gabriel
    Morisset, Stephane
    Klein, Emilie
    Chollet, Claudine
    Robbesyn, Fanny
    Turcq, Beatrice
    Tigaud, Isabelle
    Hayette, Sandrine
    Nicolini, Franck E.
    Mahon, Francois-Xavier
    ANNALS OF HEMATOLOGY, 2019, 98 (05) : 1159 - 1168
  • [39] Clinical Significance of Dose Reductions of Second-Generation Tyrosine Kinase Inhibitors (TKI) in Patients (Pts) with Chronic Myeloid Leukemia (CML)
    Santos, Fabio P. S.
    Kantarjian, Hagop
    Fava, Carmen
    O'Brien, Susan
    Garcia-Manero, Guillermo
    Komblau, Steven
    Ravandi, Farhad
    Wierda, William
    Cortes, Jorge
    BLOOD, 2008, 112 (11) : 1104 - 1104
  • [40] Chronic Myeloid Leukemia Therapy: Focus on Second-Generation Tyrosine Kinase Inhibitors
    McFarland, K. Leigh
    Wetzstein, Gene A.
    CANCER CONTROL, 2009, 16 (02) : 132 - 140
12345